Correlation Between Mineralys Therapeutics, and Myriad Genetics
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Myriad Genetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Myriad Genetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Myriad Genetics, you can compare the effects of market volatilities on Mineralys Therapeutics, and Myriad Genetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Myriad Genetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Myriad Genetics.
Diversification Opportunities for Mineralys Therapeutics, and Myriad Genetics
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mineralys and Myriad is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Myriad Genetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Myriad Genetics and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Myriad Genetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Myriad Genetics has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Myriad Genetics go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Myriad Genetics
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 1.27 times more return on investment than Myriad Genetics. However, Mineralys Therapeutics, is 1.27 times more volatile than Myriad Genetics. It trades about 0.01 of its potential returns per unit of risk. Myriad Genetics is currently generating about 0.0 per unit of risk. If you would invest 1,600 in Mineralys Therapeutics, Common on August 24, 2024 and sell it today you would lose (351.00) from holding Mineralys Therapeutics, Common or give up 21.94% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 90.93% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Myriad Genetics
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Myriad Genetics |
Mineralys Therapeutics, and Myriad Genetics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Myriad Genetics
The main advantage of trading using opposite Mineralys Therapeutics, and Myriad Genetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Myriad Genetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myriad Genetics will offset losses from the drop in Myriad Genetics' long position.| Mineralys Therapeutics, vs. Integrated Drilling Equipment | Mineralys Therapeutics, vs. Xponential Fitness | Mineralys Therapeutics, vs. Lipocine | Mineralys Therapeutics, vs. Delek Drilling |
| Myriad Genetics vs. Guardant Health | Myriad Genetics vs. Caredx Inc | Myriad Genetics vs. Castle Biosciences | Myriad Genetics vs. Sotera Health Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |